Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
at worst got a little dime size redness around the injection site; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-789840 (ModernaTX, Inc), MOD-2025-789824 (ModernaTX, Inc). An elderly patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (SPIKEVAX), as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "at worst got a little dime size redness around the injection site". Additional information: The patient received SPIKEVAX NOS for COVID-19 prophylaxis. Co-suspect product included Tozinameran (Pfizer BioNTech COVID-19 vaccine). It was reported that the patient never had a problem with Moderna vaccine or Pfizer vaccine. At worst got a little dime size redness around the injection site and sometimes used to get nothing. Batch/lot number is not provided, and it cannot be obtained.